Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure
Crossref DOI link: https://doi.org/10.1186/S13098-015-0116-2
Published: 2016-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Nathanson, David
Frick, Mats
Ullman, Bengt
Nyström, Thomas